nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

13.05.2019 | Correspondence

Recurrent Arterial and Venous Thrombosis in Chronic Immune Thrombocytopenia: Clinical Paradox and Therapeutic Challenges

verfasst von: Ankur Jain, Sumita Saluja, Sumita Chaudhry, DK Gupta

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Pishko AM, Misgav M, Cuker A, Cines DB, George JN, Vesely SK et al (2018) Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis 46:24–30CrossRefPubMedPubMedCentral

Rodeghiero F (2016) Is ITP a thrombophilic disorder? Am J Hematol 91:39–45CrossRefPubMed

El-Gendy H, El-Gohary RM, Mahfouz S, Ahmed HMA, El Demerdash DM, Ragab G (2018) Multifocal avascular necrosis in a patient with refractory immune thrombocytopenia and antiphospholipid antibodies; case report and review of literature. Platelets 29:1–8CrossRef

Mihalov J, Timárová G (2016) A seeming paradox: ischemic stroke in the context of idiopathic thrombocytopenia purpura. Clin Appl Thromb Hemost 22:115–120CrossRefPubMed

Hindi Z, Onteddu N, Ching CA, Khaled AA (2017) Vertebral artery thrombosis in chronic idiopathic thrombocytopenic purpura. Case Rep Hematol 2017:3184346PubMedPubMedCentral

Wong RS, Bakshi K, Brainsky A (2015) Thrombophilia in patients with chronic immune thrombocytopenia. Scand J Clin Lab Invest 75:13–17CrossRefPubMed

Kim WH, Park JB, Jung CW, Kim GS (2015) Rebalanced haemostasis in patients with idiopathic thrombocytopenic purpura. Platelets 26:38–42CrossRefPubMed

Hill QA (2018) Immune thrombocytopenia—in defence of the platelet count. Br J Haematol 182:128–130CrossRefPubMed

Rhee HY, Choi H-Y, Kim S-B, Shin W-C (2010) Recurrent ischaemic stroke in a patient with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 30:229–232CrossRefPubMed

10.

Le Guenno G, Guieze R, Audia S, Khellaf M, Michel M, Bonnotte B et al (2019) Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicenter study. Int Med J. https://doi.org/10.1111/imj.14269 CrossRef

Titel: Recurrent Arterial and Venous Thrombosis in Chronic Immune Thrombocytopenia: Clinical Paradox and Therapeutic Challenges
verfasst von: Ankur Jain
Sumita Saluja
Sumita Chaudhry
DK Gupta
Publikationsdatum: 13.05.2019
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-019-01136-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Recurrent Arterial and Venous Thrombosis in Chronic Immune Thrombocytopenia: Clinical Paradox and Therapeutic Challenges

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Effect of Prophylactic Management of Hemophilia on Bleeding Episodes

Mechanical Cryopreservation of Peripheral Blood Stem Cell: Initial Experience from a Tertiary Care Hospital

Clinico-Hematological Presentation of Rare Hemoglobin Variant (HB-O Indonesia) in 3 Families

Caregiver Burden in the Patients of Acute Myeloblastic Leukemia

Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Rechallenging to Hydroxycarbamide Post Thalidomide Treatment and Response in a Non Transfusion-Dependent Patient, is it Possible?

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie